SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018811
Filing Date
2023-05-08
Accepted
2023-05-08 16:11:26
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-20230331.htm   iXBRL 10-Q 2032143
2 EX-31.1 crsp-ex31_1.htm EX-31 14456
3 EX-31.2 crsp-ex31_2.htm EX-31 14456
4 EX-32.1 crsp-ex32_1.htm EX-32 13803
  Complete submission text file 0000950170-23-018811.txt   7917248

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crsp-20230331_def.xml EX-101.DEF 159467
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20230331_lab.xml EX-101.LAB 383899
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crsp-20230331_cal.xml EX-101.CAL 45639
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20230331.xsd EX-101.SCH 42659
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20230331_pre.xml EX-101.PRE 270319
54 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20230331_htm.xml XML 1739373
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 23897850
SIC: 2836 Biological Products, (No Diagnostic Substances)